Inovio Pharmaceuticals, Inc. (NYSE: INO) priced an underwritten offering of 27,377,266 shares of its common stock and warrants to purchase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE